Market overview
The global medical device testing market is worth USD 11.3 bn in 2026 and is forecast to reach USD 24.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Biocompatibility and toxicology is the largest by test type segment.
| Scope | Biocompatibility, sterility, electrical safety, performance and packaging testing services for medical devices required for regulatory approval, supplied by independent laboratories and test houses. |
|---|---|
| Industry | Testing Equipment |
| Value 2025 | USD 10.5 bn |
| Value 2026 | USD 11.3 bn |
| Value 2036 | USD 24.5 bn |
| CAGR 2026-2036 | 8.0% |
| Volume 2026 | 371 thousand test programmes |
| Volume 2036 | 656 thousand test programmes |
| Average price 2026 | USD 30,600 per test programme |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Medical Device Testing market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 11.3 bn |
| 2027 | USD 12.2 bn |
| 2028 | USD 13.2 bn |
| 2029 | USD 14.3 bn |
| 2030 | USD 15.4 bn |
| 2031 | USD 16.7 bn |
| 2032 | USD 18.0 bn |
| 2033 | USD 19.4 bn |
| 2034 | USD 21.0 bn |
| 2035 | USD 22.7 bn |
| 2036 | USD 24.5 bn |
Medical Device Testing market segmentation
By test type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biocompatibility and toxicology | 26.0% | 27.0% | USD 2.9 bn | 8.4% |
| Sterilization and microbiology | 22.0% | 20.8% | USD 2.5 bn | 7.4% |
| Electrical safety and EMC | 18.0% | 17.0% | USD 2.0 bn | 7.4% |
| Performance and mechanical | 20.0% | 20.7% | USD 2.3 bn | 8.4% |
| Packaging and shelf life | 14.0% | 14.5% | USD 1.6 bn | 8.4% |
By device class
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Class II | 48.0% | 47.4% | USD 5.4 bn | 7.9% |
| Class III and implants | 30.0% | 32.5% | USD 3.4 bn | 8.9% |
| Class I | 12.0% | 10.3% | USD 1.4 bn | 6.4% |
| In vitro diagnostics | 10.0% | 9.9% | USD 1.1 bn | 7.9% |
By provider
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Independent labs | 62.0% | 60.0% | USD 7.0 bn | 7.7% |
| Manufacturer in-house labs | 24.0% | 24.0% | USD 2.7 bn | 8.0% |
| Notified bodies and regulators | 14.0% | 16.0% | USD 1.6 bn | 9.4% |
By device technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Active devices | 34.0% | 36.0% | USD 3.9 bn | 8.6% |
| Implants | 20.0% | 20.0% | USD 2.3 bn | 8.0% |
| Single-use consumables | 26.0% | 26.0% | USD 2.9 bn | 8.0% |
| Diagnostic and software | 20.0% | 18.0% | USD 2.3 bn | 6.9% |
By regulatory region
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| FDA 510k and PMA | 40.0% | 38.0% | USD 4.5 bn | 7.5% |
| EU MDR | 28.0% | 26.0% | USD 3.2 bn | 7.2% |
| Asia and other | 32.0% | 36.0% | USD 3.6 bn | 9.3% |
Top 25 countries for medical device testing by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 95.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 4.1 bn | 36.0% | USD 8.3 bn | 7.4% |
| 2 | Germany | USD 1.0 bn | 9.0% | USD 2.2 bn | 7.9% |
| 3 | China | USD 1.0 bn | 9.0% | USD 2.7 bn | 10.4% |
| 4 | United Kingdom | USD 680 mn | 6.0% | USD 1.4 bn | 7.5% |
| 5 | Japan | USD 567 mn | 5.0% | USD 1.1 bn | 6.4% |
| 6 | France | USD 567 mn | 5.0% | USD 1.2 bn | 7.3% |
| 7 | Ireland | USD 454 mn | 4.0% | USD 979 mn | 8.0% |
| 8 | Switzerland | USD 454 mn | 4.0% | USD 979 mn | 8.0% |
| 9 | Netherlands | USD 340 mn | 3.0% | USD 734 mn | 8.0% |
| 10 | India | USD 340 mn | 3.0% | USD 1.1 bn | 12.0% |
| 11 | Canada | USD 189 mn | 1.7% | USD 419 mn | 8.3% |
| 12 | Spain | USD 167 mn | 1.5% | USD 345 mn | 7.5% |
| 13 | Sweden | USD 146 mn | 1.3% | USD 304 mn | 7.6% |
| 14 | Austria | USD 129 mn | 1.1% | USD 267 mn | 7.5% |
| 15 | Belgium | USD 113 mn | 1.0% | USD 235 mn | 7.6% |
| 16 | Israel | USD 100 mn | 0.9% | USD 220 mn | 8.2% |
| 17 | Taiwan | USD 87 mn | 0.8% | USD 193 mn | 8.3% |
| 18 | Singapore | USD 77 mn | 0.7% | USD 171 mn | 8.3% |
| 19 | Mexico | USD 68 mn | 0.6% | USD 169 mn | 9.5% |
| 20 | Australia | USD 60 mn | 0.5% | USD 132 mn | 8.2% |
| 21 | Italy | USD 52 mn | 0.5% | USD 110 mn | 7.8% |
| 22 | Poland | USD 46 mn | 0.4% | USD 115 mn | 9.5% |
| 23 | Denmark | USD 41 mn | 0.4% | USD 86 mn | 7.7% |
| 24 | Finland | USD 36 mn | 0.3% | USD 73 mn | 7.3% |
| 25 | Malaysia | USD 32 mn | 0.3% | USD 78 mn | 9.4% |
| Rest of world | USD 469 mn | 4.1% | USD 950 mn | 7.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Eurofins Scientific
- SGS
- Intertek
- TUV SUD
- UL Solutions
- Element Materials Technology
- Bureau Veritas
- TUV Rheinland
Group 2: Regional and specialist players
- Nelson Labs
- NAMSA
- WuXi AppTec
- Charles River Laboratories
- DEKRA
- Applus+
- Smithers
- Tentamus
- STERIS AST
- American Preclinical Services
Group 3: Emerging and niche players
- Pacific BioLabs
- Toxikon
- Medistri
- Wickham Laboratories
- BioScreen Testing Services
- Lucideon
- Hohenstein
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the medical device testing market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.
The market is divided by test type, by device class, by provider, by device technology, by regulatory region. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the medical device testing market?
The global medical device testing market is estimated at USD 10.5 bn in 2025 and USD 11.3 bn in 2026.
How fast will the medical device testing market grow?
It is forecast to reach USD 24.5 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 13.1 bn.
Which country is the largest market for medical device testing?
United States is the largest market by revenue at USD 4.1 bn in 2026, 36.0% of the global total. The three largest countries together hold 54.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 12.0% a year from 2026 to 2036.
Which medical device testing segment is largest?
In the by test type split, Biocompatibility and toxicology is the largest segment with 26.0% of 2026 revenue.
Who are the leading medical device testing companies?
Global leaders include Eurofins Scientific, SGS, Intertek, TUV SUD.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Testing Equipment
- Non Destructive TestingUSD 12.2 bn · 6.5% CAGR
- Water TestingUSD 10.1 bn · 6.5% CAGR
- Automotive TestingUSD 13.4 bn · 7.0% CAGR
- MicroscopeUSD 9.1 bn · 6.5% CAGR
- Surveying EquipmentUSD 8.7 bn · 6.3% CAGR
- Pharmaceutical TestingUSD 17.4 bn · 9.0% CAGR
- SpectrometerUSD 18.1 bn · 6.5% CAGR
- Electromagnetic Compatibility TestingUSD 7.0 bn · 7.0% CAGR